Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 136

Results For "RET"

1730 News Found

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19
Biotech | April 25, 2022

New studies presented at ECCMIC 2022 confirm benefit of remdesivir in treating Covid-19

Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment


Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent
Biotech | April 25, 2022

Erytech sells U.S. manufacturing facility and enters long-term supply agreement with Catalent

Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction


Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


Doctors at Yashoda successfully treated advanced-stage laryngeal cancer
Biotech | April 25, 2022

Doctors at Yashoda successfully treated advanced-stage laryngeal cancer

Deputy Mayor from Addis Ababa (Ethiopia) battled out a rare laryngeal cancer at Yashoda Hospitals Hyderabad


Marskans Pharma acquires Dubai based Access Healthcare
News | April 25, 2022

Marskans Pharma acquires Dubai based Access Healthcare

Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region


Twenty eight companies commit to Rs 6000 crore at Global Ayush meet
News | April 23, 2022

Twenty eight companies commit to Rs 6000 crore at Global Ayush meet

The commitment is expected to generate over 5.56 lakh jobs and positively impact the lives of more than 76 lakh people, the ministry said


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal
Public Health | April 22, 2022

First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal

The first use of Philips' breakthrough CavaClear solution to help patients with embedded IVC filters, including an athlete suffering from a 16-year old penetrating filter


Merck announces Joseph Romanelli will lead Merck Human Health International
News | April 21, 2022

Merck announces Joseph Romanelli will lead Merck Human Health International

In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S


Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
Drug Approval | April 21, 2022

Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses

Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses